Etesevimab
Etesevimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Etesevimab (LY-CoV016, also known as JS016) is a fully human and recombinant monoclonal antibody that targets the SARS-CoV-2 surface spike protein receptor binding domain.
| Trade Name | Etesevimab |
| Generic | Etesevimab |
| Etesevimab Other Names | Etesevimab |
| Weight | 700mg/20ml |
| Type | Intravenous solution |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | United States |
| Last Updated: | September 19, 2023 at 7:00 am |
How Etesevimab works
Etesevimab aims to neutralize SARS-CoV-2 by specifically binding to the virus' surface spike protein receptor binding domain. This high affinity binding then prevents SARS-CoV-2 from binding to the ACE2 host cell surface receptor. Etesevimab is currently being investigated against COVID-19.
Innovators Monograph
You find simplified version here Etesevimab
